Enovix (NASDAQ:ENVX) Reaches New 52-Week Low – Should You Sell?

Enovix Corporation (NASDAQ:ENVX)’s stock price reached a new 52-week low during trading on Wednesday . The company traded as low as $3.85 and last traded at $3.97, with a volume of 8363703 shares. The stock had previously closed at $4.23.

Analysts Set New Price Targets

Several equities analysts have weighed in on ENVX shares. Oppenheimer reduced their price objective on Enovix from $24.00 to $21.00 and set an “outperform” rating for the company in a report on Thursday, May 14th. TD Cowen lowered their target price on Enovix from $7.00 to $5.50 and set a “hold” rating on the stock in a research note on Friday, July 24th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Benchmark cut their price target on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Finally, Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a report on Saturday, May 16th. Six analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $12.50.

Enovix Stock Performance

The company has a market capitalization of $911.87 million, a P/E ratio of -5.04 and a beta of 2.26. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14. The company’s fifty day moving average is $6.05 and its 200 day moving average is $6.12.

Enovix (NASDAQ:ENVX) last issued its earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. The business had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $6.95 million. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The business’s revenue for the quarter was up 49.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.15) EPS. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. As a group, equities analysts anticipate that Enovix Corporation will post -0.79 earnings per share for the current year.

Institutional Trading of Enovix

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Cauble & Harre Wealth Management Inc. bought a new position in Enovix in the 4th quarter worth about $1,012,000. Vanguard Group Inc. increased its position in shares of Enovix by 10.9% during the fourth quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock valued at $129,831,000 after buying an additional 1,747,145 shares during the period. Jupiter Asset Management Ltd. increased its position in shares of Enovix by 117.6% during the fourth quarter. Jupiter Asset Management Ltd. now owns 538,190 shares of the company’s stock valued at $3,934,000 after buying an additional 290,916 shares during the period. Virtu Financial LLC purchased a new stake in shares of Enovix in the fourth quarter worth about $848,000. Finally, CenterBook Partners LP lifted its holdings in shares of Enovix by 66.1% in the fourth quarter. CenterBook Partners LP now owns 1,757,382 shares of the company’s stock worth $12,846,000 after buying an additional 699,519 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.